Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye

Summary

This phase II trial studies how well giving cixutumumab works in treating patients with metastatic melanoma of the eye. Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them.

Timeline

Start

2011-08

Primary completion

2013-03

Completion

2014-06

Drugs

Indications